Waddill William D. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$3.99M

Insider Activity of Waddill William D.

According to the SEC Form 4 filings, Waddill William D., being in a position of

  1. director at Arrowhead Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 8367 shares for $566,038,
    over all time since 2019-01-11, has bought 0 shares, and sold 77246 shares for $2.97M.

Biography of Waddill William D.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$5,166,9785100

Comparison of Insiders on Amount of Buys and Sells

2026-06-23SaleProtagonist Therapeutics, Inc.
PTGX
director
9,000
0.0139%
$117.94$1.06M+18.22%
2026-06-10SaleProtagonist Therapeutics, Inc.
PTGX
director
9,000
0.0142%
$107.68$969,120+32.42%
2026-05-29SaleProtagonist Therapeutics, Inc.
PTGX
director
9,000
0.014%
$99.64$896,760+39.81%
2026-02-06SaleProtagonist Therapeutics, Inc.
PTGX
director
20,000
0.0317%
$83.68$1.67M+42.38%
2025-12-19SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
8,367
0.006%
$67.65$566,038+2.66%
2025-10-10SaleProtagonist Therapeutics, Inc.
PTGX
director
12,000
0.0181%
$81.62$979,480+14.02%
2025-09-22SaleProtagonist Therapeutics, Inc.
PTGX
director
4,000
0.0064%
$64.25$257,000+50.95%
2025-08-27SaleProtagonist Therapeutics, Inc.
PTGX
director
4,000
0.0062%
$59.25$237,000+49.91%
2025-03-17SaleProtagonist Therapeutics, Inc.
PTGX
director
4,000
0.0067%
$54.25$217,000+14.19%
2024-12-17SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
3,747
0.003%
$22.04$82,584-14.98%
2024-12-16SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
3,748
0.003%
$21.90$82,081-15.36%
2024-09-10SaleProtagonist Therapeutics, Inc.
PTGX
director
8,000
0.0136%
$45.00$360,000+2.13%
2024-07-24SaleProtagonist Therapeutics, Inc.
PTGX
director
8,000
0.013%
$40.00$320,000+5.99%
2024-06-07SaleProtagonist Therapeutics, Inc.
PTGX
director
8,000
0.0137%
$35.00$280,000+19.77%
2024-03-01SaleProtagonist Therapeutics, Inc.
PTGX
director
12,975
0.0219%
$31.34$406,637+17.67%
2024-01-11SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
3,934
0.0037%
$38.07$149,759-34.49%
2023-01-09SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
3,200
0.003%
$30.00$96,000+0.59%
2022-01-03SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
4,500
0.0039%
$64.72$291,244-43.25%
2021-01-04SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
3,750
0.0037%
$76.08$285,300-7.79%
2020-12-10SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
3,000
0.0028%
$71.26$213,780-5.75%
Total: 22
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.